Skip to main content
. Author manuscript; available in PMC: 2020 Feb 14.
Published in final edited form as: Vaccine. 2019 Jan 23;37(8):1094–1100. doi: 10.1016/j.vaccine.2018.12.075

Table 4.

Antimicrobial resistance profiles for S. pneumoniae isolates (N = 45) detected by culture method.

Susceptible Intermediate Resistant
Amoxicillin 42 (93.3%) 2 (4.4%) 1 (2.2%)
Cefotaxime 44 (97.8%) 1 (2.2%) 0
Ceftriaxone 44 (97.8%) 1 (2.2%) 0
Cefuroxime 38 (84.4%) 4 (8.9%) 3 (6.7%)
Chloramphenicol 45 (100%) 0 0
Ciprofloxacin 45 (100%) 0 0
Clindamycin 42 (93.3%) 0 3 (6.7%)
Erythromycin 30 (66.7%) 0 15 (33.3%)
Levofloxacin 45 (100%) 0 0
Linozelid 45 (100%) 0 0
Meropenem 42 (93.3%) 1 (2.2%) 2 (4.4%)
Penicillin 32 (71.1%) 10 (22.2%) 3 (6.7%)
Quinupristin/Dalfopristin 45 (100%) 0 0
Rifampin 45 (100%) 0 0
Tetracycline 40 (89.9%) 0 5 (11.1%)
Trimethoprim-sulfaethoxazole 39 (86.7%) 4 (8.9%) 2 (4.4%)
Vancomycin 45 (100%) 0 0